Vice President of development corporate, Cellectis
David J.D. Sourdive, Ph.D., co-founded Coellectis SA with Dr. Choulika, and has served as Director since 2000. Prior to inception of the company, Dr. Sourdive was the head of Biotechnology Laboratory at the Centre d'Etudes du Bouchet (French Ministry of Defense). At the same time, Dr. Sourdive was heading a research group in Immunology at the Pasteur Institute. Dr. Sourdive attended Ecole Polytechnique and received a Ph. D. in Molecular Virology from University of Paris VII / Institut Pasteur. Dr. Sourdive then applied recombination tracking technologies to anti-viral immune memory, at the Emory University Vaccine Center in Atlanta.
- Cellectis: structuring a worldwide leader in genome engineering (Coming soon)
Through ambitious programs and with the EU support, Cellectis is developing its leadership in genome engineering, a structuring and emerging industrial sector.